Levi & Korsinsky is investigating the Board of Directors of ATS Medical, Inc. (“ATS Medical” or the “Company”) (NasdaqGM: ATSI) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Medtronic Inc. ("Medtronic") (NYSE: MDT). Under the terms of the transaction, ATS Medical shareholders will receive $4.00 in cash for each ATS Medical share of common stock they own for a total transaction value of approximately $370 million.

The investigation concerns whether the ATS Medical Board of Directors breached their fiduciary duties to ATS Medical stockholders by failing to adequately shop the Company before entering into this transaction and whether Medtronic is underpaying for ATS Medical shares, thus unlawfully harming ATS Medical stockholders. At least one analyst set a price target for ATS Medical stock at $5.00 per share and the Board of Directors agreed to a strict "no solicitation" provision and agreed to pay Medtronic a termination fee of $13 million, under certain circumstances.

If you own common stock in ATS Medical and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500 or visit http://www.zlk.com/ats-medical-atsi.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.

Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Ats Medical (MM).
Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Ats Medical (MM).